Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00649389 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension
A Phase 3 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,500
- Enrollment target
NCT00649389: Completed Phase 3 study, sponsored by Daiichi Sankyo.
NCT00649389 is a Phase 3 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 2,500 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (224% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00649389, a Phase 3 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,500 participants
- Enrollment target
Study Summary
To determine the effectiveness of four different strength combinations of three approved anti-hypertension therapies (olmesartan medoxomil, amlodipine, and hydrochlorothiazide) for lowering blood pressure.
Interventions
- DRUG Amlodipine
- DRUG Olmesartan medoxomil
- DRUG Hydrochlorothiazide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-12 |
| Phase | Phase 3 |
What the finished NCT00649389 record still lists
NCT00649389 is an interventional study that assigns participants to a tested intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (224% higher).
The record links to 0 conditions, and to 3 interventions - of which Amlodipine is the first listed.
NCT00649389 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00649389 about?
NCT00649389 is a clinical study titled "Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension". To determine the effectiveness of four different strength combinations of three approved anti-hypertension therapies (olmesartan medoxomil, amlodipine, and hydrochlorothiazide) for lowering blood pressure.
What is the current status of trial NCT00649389?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,500 participants. The study started on 2008-05. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00649389?
The interventions under investigation include: Amlodipine (DRUG), Olmesartan medoxomil (DRUG), Hydrochlorothiazide (DRUG).
Who is sponsoring clinical trial NCT00649389?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00649389's enrollment target sits among peer trials
2,500 88th of 2000 higher than 1,913 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia